viewBryah Resources Ltd

Bryah Resources in trading halt ahead of capital raising news

The company is adding gold and copper to its exploration strategy alongside manganese.

Bryah Resources Ltd - Bryah Resources Ltd in trading halt ahead of capital raising news
Bryah is a Perth-based mining company with projects in the Bryah Basin and at Gabanintha in the Meekatharra region of WA

Bryah Resources Ltd (ASX:BYH) is in trading halt pending capital raising news.

The trading halt will remain in place until the beginning of trade on Monday August 26 or when an announcement is made to market – whichever occurs earliest.

High-grade manganese mineralisation extension

The company identified further high-grade manganese mineralisation in phase-two reverse circulation (RC) drilling earlier this week within the Main Pit area at its Horseshoe South Manganese Mine.

The 83-hole, 2,081-metre program was funded by a subsidiary of manganese specialist OM Holdings Ltd (ASX:OMM) under a $7.3 million farm-in and joint venture agreement signed in April.

Bryah managing director Neil Marston said the final results from second phase drilling confirmed the potential for zones of high-grade manganese mineralisation to be present just below the existing open pit surface.

Gold-copper targets at Gabanintha

The company is also set to drill 1,500 metres in an RC program at the high-grade Tumblegum South gold-copper prospect within its Gabanintha Project in WA.

Drilling will begin in September and be based off 3D modelling which has identified potential opportunities to extend existing zones of gold-copper mineralisation at Tumblegum South.

Quick facts: Bryah Resources Ltd

Price: 0.07 AUD

Market: ASX
Market Cap: $10.75 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Orthocell's Paul Anderson hails FDA approval for dental bone and tissue...

Orthocell Ltd's (ASX:OCC) Paul Anderson caught up with Proactive's Andrew Scott soon after announcing they've received Food and Drug Administration’s (FDA) 510(k) clearance to market and supply its CelGro collagen medical device for dental bone and tissue regeneration procedures in the US....

1 day, 1 hour ago

2 min read